Fixed-Dose Drug Combination for Treatment of Tuberculosis

被引：0
作者：
Mathew, Joseph L. [1 ]
机构：
[1] Postgrad Inst Med Educ & Res, Adv Pediat Ctr, Chandigarh 160012, India
来源：
INDIAN PEDIATRICS | 2009年 / 46卷 / 10期
关键词：
PULMONARY TUBERCULOSIS; GLOBAL MARKET; CHEMOTHERAPY; PYRAZINAMIDE; INDONESIA; RIFAMPIN; REGIMEN;
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：877 / 880
页数：4
相关论文
共 17 条
[1]   Fixed-dose combinations improve medication compliance: A meta-analysis [J].
Bangalore, Sripal ;
Kamalakkannan, Gayathri ;
Parkar, Sanobar ;
Messerli, Franz H. .
AMERICAN JOURNAL OF MEDICINE, 2007, 120 (08) :713-719
[2]  
Bartacek A, 2009, INT J TUBERC LUNG D, V13, P760
[3]   Mechanistic explanation to the catalysis by pyrazinamide and ethambutol of reaction between rifampicin and isoniazid in anti-TB FDCs [J].
Bhutani, H ;
Singh, S ;
Jindal, KC ;
Chakraborti, AK .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 39 (05) :892-899
[4]  
Blomberg B, 2001, B WORLD HEALTH ORGAN, V79, P61
[5]  
GIRLING DJ, 1989, AM REV RESPIR DIS, V140, P1618
[6]   Preliminary results of an operational field study to compare side-effects, complaints and treatment results of a single-drug short-course regimen with a four-drug fixed-dose combination (4FDC) regimen in South Sulawesi, Republic of Indonesia [J].
Gravendeel, JMT ;
Asapa, AS ;
Becx-Bleumink, M ;
Vrakking, HA .
TUBERCULOSIS, 2003, 83 (1-3) :183-186
[7]  
Laserson KF, 2001, INT J TUBERC LUNG D, V5, P448
[8]  
Moulding TS, 2004, INT J TUBERC LUNG D, V8, P743
[9]  
Nyazema N. Z., 1999, Central African Journal of Medicine, V45, P141
[10]  
Pillai G, 1999, INT J TUBERC LUNG D, V3, pS309
12